technetium-tc-99m-exametazime has been researched along with Leukemia--Myeloid--Acute* in 2 studies
2 other study(ies) available for technetium-tc-99m-exametazime and Leukemia--Myeloid--Acute
Article | Year |
---|---|
Tc-99m HMPAO labeled white blood cell imaging in a child with eosinophilic lung disease.
In radiolabeled leukocyte imaging, Tc-99m HMPAO has a significantly higher selectivity for eosinophils than neutrophils, but this may be clinically meaningful in disorders with eosinophilic infiltration. We present the case of a 2-year-old boy with infection who also developed drug-induced eosinophilic lung disease, as established later by bronchoalveolar lavage and discontinuation of the responsible antistaphylococcal agent. In the investigation of sepsis, diffusely increased pulmonary accumulation of Tc-99m HMPAO labeled leukocytes was observed. These findings were consistent with eosinophilic lung infiltration and underline the importance of clinical and laboratory data in the comprehensive interpretation of Tc-99m HMPAO labeled leukocytes scans. Topics: Acetamides; Anti-Infective Agents; Child, Preschool; Humans; Leukemia, Myeloid, Acute; Leukocytes; Linezolid; Magnetic Resonance Imaging; Male; Oxazolidinones; Pulmonary Eosinophilia; Radionuclide Imaging; Radiopharmaceuticals; Staphylococcal Infections; Technetium Tc 99m Exametazime | 2008 |
Acute myelogenous leukemia and glycogen storage disease 1b.
Glycogen storage disease 1b (GSD 1b) is caused by a deficiency of glucose-6-phosphate translocase and the intracellular accumulation of glycogen. The disease presents with failure to thrive, hepatomegaly, hypoglycemia, lactic acidosis, as well as neutropenia causing increased susceptibility to pyogenic infections. We present a case of a young woman with GSD 1b who developed acute myelogenous leukemia while on long-term granulocyte colony-stimulating factor therapy. The presence of two rare diseases in a single patient raises suspicion that GSD 1b and acute myelogenous leukemia are linked. Surveillance for acute myelogenous leukemia should become part of the long-term follow-up for GSD 1b. Topics: Female; Glycogen Storage Disease Type I; Granulocyte Colony-Stimulating Factor; Humans; Infant; Leukemia, Myeloid, Acute; Radionuclide Imaging; Radiopharmaceuticals; Recombinant Proteins; Technetium Tc 99m Exametazime | 2002 |